Previously, it has been shown that EZH2 mediates transcriptional silencing of E-cadherin by trimethylation of H3K27 and that HDAC inhibitors could attenuate tumor invasion by blocking EZH2- mediated repression of E-cadherin [14]. Here, EZH2 is linked to neoplasm.